| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 4 | 9 | 2010 | 2012 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 4 | 17 | 2010 | 2017 | ||||||||
|
iron responsive element binding protein 2 | 0.619 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 33 | 2010 | 2010 | ||||||||
|
proteasome 20S subunit alpha 4 | 0.716 | 0.385 | 0.60 |
|
phenotype | 0.100 | None | 1.000 | 3 | 10 | 2010 | 2010 | ||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 8 | 2010 | 2012 | |||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 3 | 13 | 2010 | 2017 | ||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2012 | |||||||||
|
egl-9 family hypoxia inducible factor 2 | 0.604 | 0.731 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2012 | ||||||||
|
ribosomal protein L18 pseudogene 11 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2010 | |||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2012 | ||||||||
|
mortality factor 4 like 1 | 0.736 | 0.423 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 21 | 2010 | 2010 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
phenotype | 0.100 | None | 1.000 | 2 | 52 | 2010 | 2010 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 7 | 0.666 | 0.577 | 2.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 2 | 17 | 2010 | 2010 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2010 | 2010 | ||||||||
|
phosphodiesterase 1C | 0.700 | 0.423 | 5.4E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 46 | 2010 | 2010 | ||||||||
|
Enah/Vasp-like | 0.729 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
RAB4B, member RAS oncogene family | 0.890 | 0.192 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
RNA binding fox-1 homolog 1 | 0.584 | 0.692 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
serine/threonine kinase 33 | 0.666 | 0.346 | 2.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
RAB3B, member RAS oncogene family | 0.861 | 0.115 | 0.31 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2010 | 2010 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2017 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 | 0.682 | 0.423 | 1.5E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
long intergenic non-protein coding RNA 1081 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
cholinergic receptor nicotinic beta 3 subunit | 0.705 | 0.308 | 8.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 7 | 2010 | 2010 |